{"entity":{"type":"insider","cik":"0001631671","url":"/insider/0001631671","json_url":"/insider/0001631671.json","name":"Ritter Andrew J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2016-02-24","last":"2020-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Ritter Andrew J","source":"filing","n_filings":3,"first_seen":"2016-02-24","last_seen":"2020-03-13"}],"transactions":[{"id":3100409,"accession":"0001382963-20-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001382963-20-000030","line_url":"/filing/0001382963-20-000030#line-1","is_derivative":false,"issuer_cik":"0001460702","issuer_name":"RITTER PHARMACEUTICALS INC","issuer_ticker":"RTTR","issuer_name_source":null,"issuer_url":"/issuer/0001460702","owner_cik":"0001631671","owner_name":"Ritter Andrew J","owner_url":"/insider/0001631671","role":"Director, Officer (CEO and President)","officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18750.0,"shares_display":"18,750","price_per_share":0.3756,"price_display":"0.38","price_state":"stated","total_value":7042.5,"total_display":"7,042.50","shares_owned_after":81727.0,"shares_owned_after_display":"81,727","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-13","scope":"insider"},{"id":4341045,"accession":"0001382963-17-000172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001382963-17-000172","line_url":"/filing/0001382963-17-000172#line-1","is_derivative":false,"issuer_cik":"0001460702","issuer_name":"RITTER PHARMACEUTICALS INC","issuer_ticker":"RTTR","issuer_name_source":null,"issuer_url":"/issuer/0001460702","owner_cik":"0001631671","owner_name":"Ritter Andrew J","owner_url":"/insider/0001631671","role":"Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":1004772.0,"shares_owned_after_display":"1,004,772","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-03","filed_date":"2017-10-27","scope":"insider"},{"id":2685296,"accession":"0001382963-16-000152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001382963-16-000152","line_url":"/filing/0001382963-16-000152#line-1","is_derivative":false,"issuer_cik":"0001460702","issuer_name":"RITTER PHARMACEUTICALS INC","issuer_ticker":"RTTR","issuer_name_source":null,"issuer_url":"/issuer/0001460702","owner_cik":"0001631671","owner_name":"Ritter Andrew J","owner_url":"/insider/0001631671","role":"Director, Officer (President), Ten percent owner","officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","shares_owned_after":6250.0,"shares_owned_after_display":"6,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-22","filed_date":"2016-02-24","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001460702","name":"RITTER PHARMACEUTICALS INC","url":"/issuer/0001460702","role":"Director, Officer (CEO and President), Ten percent owner","n_filings":3,"first_seen":"2016-02-24","last_seen":"2020-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001631671","retrieved_at":"2026-08-21T11:15:40+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}